XML 35 R25.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value
The following is a summary of our financial instruments measured at fair value on a recurring basis (in thousands):
September 30, 2024Level 1Level 2Level 3Total
Cash equivalents:
Money market funds$21,487 $— $— $21,487 
Certificates of deposit3,490 — — 3,490 
Endospan Loans  4,059 4,059 
Total assets$24,977 $ $4,059 $29,036 
Long-term liabilities:
Contingent consideration— — (51,720)(51,720)
Total liabilities$ $ $(51,720)$(51,720)
December 31, 2023Level 1Level 2Level 3Total
Cash equivalents:
Money market funds$22,802 $— $— $22,802 
Certificates of deposit3,968 — — 3,968 
Total assets$26,770 $ $ $26,770 
Long-term liabilities:
Contingent consideration— — (63,890)(63,890)
Total liabilities$ $ $(63,890)$(63,890)
Schedule of Reconciliation of Changes in Fair Value of Level 3 Liabilities Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):
Endospan Loans
Balance as of December 31, 2023— 
Initial value of Endospan Loans3,517 
Change in valuation 542 
Balance as of September 30, 2024$4,059 
Contingent Consideration
Balance as of December 31, 2023$(63,890)
Change in valuation 12,170 
Balance as of September 30, 2024$(51,720)